Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multiple-encrypted DNA device for secure communication.

Science advances·2026
Same author

Programming Dimensional Transitions in DNA Brick Crystals via Interfacial Connectivity.

Angewandte Chemie (International ed. in English)·2026
Same author

Collaborative Pt-Ni Sites Enable CO-Tolerant Hydrocracking for Upcycling Polyolefin Waste.

Journal of the American Chemical Society·2026
Same author

Structure-Controlled Molecular Recognition and Charge Transport in Metallized DNA Nanosheets.

Journal of the American Chemical Society·2026
Same author

Author Correction: Atomically precise photothermal nanomachines.

Nature materials·2026
Same author

L-DNA-Based Framework Nucleic Acid Nanodevice for Lysosomal ATP Imaging.

Analytical chemistry·2026
Same journal

Decoding Galectin-Glycan Recognition with <sup>19</sup>F-Tagged Lectins: from Simple Glycans to the Cellular Glycocalyx.

Journal of the American Chemical Society·2026
Same journal

Open- and Closed-Shell Roles of Sensitizer and Annihilator in Pseudo-Single Component Mixtures for Upconversion.

Journal of the American Chemical Society·2026
Same journal

Pressure-Induced Superconductivity at 15 K in van-der-Waals Ferroelectric CuInP<sub>2</sub>S<sub>6</sub>.

Journal of the American Chemical Society·2026
Same journal

Carbene Analogues of Group 15: Reduction of s-Hydrindacene-Based Chloropnictogenium Ions To Access an Antimony Hydride Monocation and a Trinuclear Bismuth Dication.

Journal of the American Chemical Society·2026
Same journal

Chiral-Ligand-Modulated Nickel-Catalyzed Stereoselective Radical Migratory C2-Arylation of Carbohydrates.

Journal of the American Chemical Society·2026
Same journal

Coordination-Constraint-Driven Enhanced Chirality Induction in Perovskite Quantum Dot Solids.

Journal of the American Chemical Society·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

DNA-Engineered Degradable Invisibility Cloaking for Tumor-Targeting Nanoparticles.

Yan Zhao1,2, Junjun Hou3, Linjie Guo1

  • 1Institute of Materiobiology, College of Sciences, Shanghai University, Shanghai 200444, China.

Journal of the American Chemical Society
|August 28, 2024
PubMed
Summary
This summary is machine-generated.

Scientists developed DNA-engineered invisibility cloaking (DEIC) to prevent nanoparticle sequestration by the liver. This novel approach enhances targeted delivery of nanoagents to tumors in vivo.

More Related Videos

Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.2K
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
08:04

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging

Published on: June 21, 2011

18.3K

Related Experiment Videos

Last Updated: Jun 15, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K
Viral Nanoparticles for In vivo Tumor Imaging
14:04

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

17.2K
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
08:04

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging

Published on: June 21, 2011

18.3K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Drug Delivery

Background:

  • Nanoparticle (NP) delivery systems are crucial for cancer therapy and vaccines.
  • Liver sequestration of NPs significantly hinders targeted delivery efficiency.
  • Overcoming liver phagocytosis is essential for effective in vivo nanoagent delivery.

Purpose of the Study:

  • To develop a DNA-engineered strategy to circumvent liver phagocytosis.
  • To enhance tumor-targeted delivery of nanoagents using a novel cloaking method.
  • To investigate the potential of DNA-engineered invisibility cloaking (DEIC) for theranostic applications.

Main Methods:

  • Coating NPs with a DNA monolayer to adsorb dysopsonin proteins and induce liver invisibility.
  • Utilizing the tunable degradation of DNA shells in vivo to trigger tumor-specific uptake.
  • Evaluating DEIC using Ag2S quantum dots and nanoliposomes in mouse models.
  • Employing near-infrared-II imaging to quantify tumor-to-liver delivery ratios.

Main Results:

  • The DNA monolayer on NPs preferentially adsorbed serum dysopsonin proteins, rendering them functionally invisible to the liver.
  • Tumor-specific uptake was achieved through the in vivo degradation of the DNA shell, with tunable degradation rates.
  • DEIC demonstrated efficacy in both Ag2S quantum dot and nanoliposome systems.
  • Near-infrared-II imaging showed a high tumor-to-liver ratio of up to ~5.1, an 18-fold improvement over conventional nanomaterials.

Conclusions:

  • DNA-engineered invisibility cloaking (DEIC) effectively circumvents liver sequestration of NPs.
  • This approach significantly enhances tumor-targeted delivery of nanoagents in vivo.
  • DEIC offers a potentially universal strategy for high-efficiency targeted delivery of theranostic agents.